MS
Muthukaruppan Srinivasan
About Muthukaruppan Srinivasan
Data last updated:
Muthukaruppan Srinivasan is a Director at Cu-V-Kar Genetic Medicine Private Limited (since 2007), Director at Hfa Formulations Private Limited (since 2019) and Director at Viencee Pharma Science Private Limited (since 2017), and holds 2 more current directorships. The companies operate in Pharma and Paper. The 4 current companies with reported revenue have a combined latest revenue of ₹72.32 Cr; the largest is Cu-V-Kar Genetic Medicine Private Limited at ₹55.11 Cr (FY 2024). Earlier, Muthukaruppan Srinivasan was a Director at Consonance Technology Solutions Private Limited (from 2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 04 Jan 2007 | 2007 | ₹55.11 Cr (FY 2024) | Active | |
| Director | 14 Jun 2019 | 2015 | ₹15.65 Cr (FY 2024) | Active | |
| Director | 11 Jul 2017 | 2017 | ₹1.54 Cr (FY 2024) | Active | |
| Director | 05 Jul 2023 | 2023 | ₹1.1 Lakh (FY 2025) | Active | |
| Director | 20 Sep 2023 | 2023 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 14 Jun 2019 | 2008 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Muthukaruppan Srinivasan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ramkumar Srinivasan | 00731177 | Cu-V-Kar Genetic Medicine Private Limited , Hfa Formulations Private Limited and 3 more | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Muthukaruppan Srinivasan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Muthukaruppan Srinivasan
Muthukaruppan Srinivasan currently holds 5 directorships: Cu-V-Kar Genetic Medicine Private Limited (Director, since 04 Jan 2007, revenue ₹55.11 Cr (FY 2024)); Hfa Formulations Private Limited (Director, since 14 Jun 2019, revenue ₹15.65 Cr (FY 2024)); Viencee Pharma Science Private Limited (Director, since 11 Jul 2017, revenue ₹1.54 Cr (FY 2024)); Cu-V-Kar Pharmacuticals Private Limited (Director, since 05 Jul 2023, revenue ₹1.1 Lakh (FY 2025)); Mm Pharma Medicines Private Limited (Director, since 20 Sep 2023).
Muthukaruppan Srinivasan was first appointed on 04 Jan 2007 as Director at Cu-V-Kar Genetic Medicine Private Limited. The most recent appointment on record is 20 Sep 2023 at Mm Pharma Medicines Private Limited.
The 4 current companies of Muthukaruppan Srinivasan that report revenue have a combined latest revenue of ₹72.32 Cr: Cu-V-Kar Genetic Medicine Private Limited ₹55.11 Cr (FY 2024); Hfa Formulations Private Limited ₹15.65 Cr (FY 2024); Viencee Pharma Science Private Limited ₹1.54 Cr (FY 2024); Cu-V-Kar Pharmacuticals Private Limited ₹1.1 Lakh (FY 2025).
Muthukaruppan Srinivasan held 1 earlier board appointment: Consonance Technology Solutions Private Limited (Director, from 14 Jun 2019).
The current boards of Muthukaruppan Srinivasan's companies include Ramkumar Srinivasan (Cu-V-Kar Genetic Medicine Private Limited).